Research advances on short-chain fatty acids in gastrointestinal acute graft- versus-host disease
- PMID: 38558826
- PMCID: PMC10979536
- DOI: 10.1177/20406207241237602
Research advances on short-chain fatty acids in gastrointestinal acute graft- versus-host disease
Abstract
Gastrointestinal acute graft-versus-host disease (GI-aGVHD) is a severe early complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). It has been shown that the intestinal microbiota plays a critical role in this process. As metabolites of the intestinal microbiota, short-chain fatty acids (SCFAs) are vital for maintaining the host-microbiota symbiotic equilibrium. This article provides an overview of the protective effect of SCFAs in the gastrointestinal tract, emphasizes their association with GI-aGVHD, and explores relevant research progress in prevention and treatment research.
Keywords: acute graft-versus-host disease; allogeneic hematopoietic stem-cell transplantation; short-chain fatty acids.
Plain language summary
Research advances on short-chain fatty acids in gastrointestinal acute graft-versus-host disease Gastrointestinal acute graft-versus-host disease (GI-aGVHD) is a severe early complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). It has been shown that the intestinal microbiota plays a critical role in this process. As metabolites of the intestinal microbiota, short-chain fatty acids (SCFAs) are vital for maintaining the host-microbiota symbiotic equilibrium. This article provides an overview of the protective effect of SCFAs in the gastrointestinal tract, emphasizes their association with GI-aGVHD and explores relevant research progress in prevention and treatment research.
© The Author(s), 2024.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Similar articles
-
Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation.Transpl Immunol. 2023 Jun;78:101836. doi: 10.1016/j.trim.2023.101836. Epub 2023 Apr 8. Transpl Immunol. 2023. PMID: 37037266 Clinical Trial.
-
Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis.Semin Hematol. 2020 Jan;57(1):1-6. doi: 10.1053/j.seminhematol.2020.06.001. Epub 2020 Jun 11. Semin Hematol. 2020. PMID: 32690138 Free PMC article. Review.
-
Human Amniotic Membrane-Derived Mesenchymal Stem Cells Prevent Acute Graft-Versus-Host Disease in an Intestinal Microbiome-Dependent Manner.Transplant Cell Ther. 2024 Feb;30(2):189.e1-189.e13. doi: 10.1016/j.jtct.2023.11.005. Epub 2023 Nov 7. Transplant Cell Ther. 2024. PMID: 37939900
-
An investigation of the potential association between gastrointestinal viral and bacterial infection and development of intestinal acute graft versus host disease following allogeneic hematopoietic stem cell transplantation.J Med Virol. 2021 Aug;93(8):4773-4779. doi: 10.1002/jmv.26892. Epub 2021 Mar 1. J Med Virol. 2021. PMID: 33605457
-
The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease.J Immunol Res. 2015;2015:145859. doi: 10.1155/2015/145859. Epub 2015 May 18. J Immunol Res. 2015. PMID: 26090477 Free PMC article. Review.
References
-
- Billingham RE. The biology of graft-versus-host reactions. Harvey Lect 1966; 62: 21–78. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials